These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24946517)

  • 1. [Neoadjuvant chemo (chemoradio) therapy for advanced non-small cell lung cancer].
    Yokomise H
    Nihon Geka Gakkai Zasshi; 2014 May; 115(3):120-4. PubMed ID: 24946517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the value of neoadjuvant therapy in bronchial carcinoma?].
    Digel W; Brethner L; Hasse J
    Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
    Burfeind WR; Harpole DH
    Semin Thorac Cardiovasc Surg; 2005; 17(3):186-90. PubMed ID: 16253820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical lung resection after neoadjuvant chemoradiotherapy.
    Burrows WM
    Semin Thorac Cardiovasc Surg; 2007; 19(4):360-5. PubMed ID: 18395639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of chemoradiotherapy followed by surgical resection in locally advanced non-small-cell lung cancer].
    Futamura Y; Sawa T; Hasegawa T; Horiba A; Ishiguro T; Yoshida T; Kinoshita T; Marui T; Murakami E; Azuma K; Murakawa S; Iida T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2390-2. PubMed ID: 23268087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of chemo(radio)theray prior to surgery for stage IIIa non-small cell lung carcinoma (localized non-resectable tumor)].
    Smit EF; van Mourik JC; Slotman BJ; Postmus PE
    Ned Tijdschr Geneeskd; 1999 Oct; 143(40):1992-6. PubMed ID: 10535055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer].
    Tsuboi M; Kato H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1538-42. PubMed ID: 17940368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
    Girard N; Mornex F
    Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant therapy for non-small cell lung cancer.
    Gandara DR; Lara PN; Goldberg Z; Roberts P; Lau DH
    Anticancer Drugs; 2001 Feb; 12 Suppl 1():S5-9. PubMed ID: 11340902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of neoadjuvant therapy in the treatment of locally advanced, stage III non-small-cell lung cancer].
    Balikó Z; Sárosi V
    Magy Onkol; 2005; 49(2):161-8. PubMed ID: 16249813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.